Search Results
Results found for "Haicang Zhang"
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
lanthanide probes, the team realized they could tune these molecules to become exquisitely sensitive to pH changes : Endogenous GLP-1 internalization shown in beta cells đ 2025: Revvity launches pHSense A Day That Changed questions about constitutive activity, agonist-induced internalization, and cellular dynamics. đ What Changed
- Understanding Orthosteric Binding: The Key to Drug Action
. đ Whether you're new to pharmacology or brushing up on basics, this lesson will change how you think The receptor may change shape upon binding, affecting how the drug interacts and how effective it will
- Orthosteric Binding Experiments: How to Avoid the Most Common Data Pitfalls
How two-stage GPCR binding creates âhighâ and âlowâ affinity states What temporal kinetics quietly change Changing tracer concentration moves the displacement curve. Changing receptor expression or G protein levels does not  remove curve heterogeneity. Non-specific binding control:  Adsorption to surfaces changes free ligand concentration.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Allostery and Biased Signaling Change the Game The most profound change in GPCR drug discovery is our discovery teams, pharmacologists refining core skills, and R&D leads who need clear reasoning in a rapidly changing
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
Medicinal Chemistry  2020 , 188 , 112037. https://doi.org/10.1016/j.ejmech.2020.112037 . (15)     Zhang Discovery  2010 , 15 (10), 1248â1259. https://doi.org/10.1177/1087057110384611 . (25)     Fulp, A.; Zhang
- Fluorescence based HTS compatible ligand binding assays for dopamine D3 receptors in baculovirus preparations and live cells
Fluorescence Anisotropy and BBV â The theory behind the assays FA is based on measuring the change in Figure 1.Time course of FA change caused by CELT-419 binding to D3 receptor on the BBV particles. The insert shows the Log(IC50) ± SE change in time of corresponding displacement curves. The Log(IC50) change in time was fitted with equation 3  and k given is the weighted average from 3 H.; Bates, M.; Zhuang, X.
- Early Stage Biotech Hiring: What Really Holds a Team Together When the Science Starts to Drift
In environments where the plan changes often, usefulness becomes the multiplier. Usefulness reveals itself only under pressure. â Recognizing this difference changes how founders evaluate It also changes what questions matter when building the team. despite missing information. 2ïžâŁ How they react to shifting priorities: Ask about situations where plans changed
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
Allosteric sites operate differently: ligands bind elsewhere, transmit energy changes, and shift the How Conformational Changes Drive Affinity and Efficacy A key takeaway from this session: affinity and Thatâs where Terryâs Corner changes the game.
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
neuromodulator, neurotransmitter, etc.), binds to the extracellular binding site of the GPCR, the protein changes the ÎČ2 adrenergic receptor (ÎČ2AR; PDB ID: 2RH1); (B) A ligand-bound GPCR undergoes a conformational change The conformation change induced by the agonist may not always lead to the same intracellular signaling
- Therapeutic validation of an orphan G proteinâcoupled receptor
these ligands are orthosteric agonists such as alkylpyrimidineâ4,6âdiol derivatives (Liu et al., 2016; Zhang
- GPCR Collaboration: From Models to Medicine
That perspective changed the moment he entered GPCR research . That candor changes the tone of collaboration . Pharmacologists know they arenât being oversold. It also allows Carlsson to stay plugged into the fast-changing needs of biotech while keeping his academic
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⊿ Nov 24 - Dec 1, 2024
Ramona Birke , Joshua Levitz , Ben Jones , Johannes Broichhagen Design of allosteric modulators that change This change is all about keeping our community strong and delivering top-notch content. the discovery of antibodies, which recognized native receptor Design of allosteric modulators that change predicted by combinatorial computational strategy Uncovering conserved networks and global conformational changes
- Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery
is like adjusting the brightness on a microscopeâset it right, and hidden details jump into focus, changing Can changing receptor density predict how your drug will behave across sensitive versus less sensitive Thatâs where Terryâs Corner  changes the game.
- The Chemistry of Confidence: Aha Moments That Shape Scientific Careers
âThe first time I wore my lucky cactus shirt to a major meeting... and it led to a game-changing collaboration
- đ° GPCR Weekly News, April 29 to May 5, 2024
announcements in todayâs episode, so join us in this celebration and be the first to know about all the changes
- From Pipettes to Platforms: The Evolution of GPCR Research
What Changed After This : High-throughput capabilities meant researchers could map GPCR signaling more But the heart of the field hasnât changed.
- G protein coupling and activation of the metabotropic GABAB heterodimer
Cryo-electron microscopy studies revealed a drastic conformational change upon activation and a unique metadynamics computations to predict the mechanism by which the inactive GP induces conformational changes
- Why âDisplacementâ Misleads You: Allosteric Binding Demystified
Session, Youâll Gain: â A clear explanation of why allosteric modulators donât displace ligandsâthey change Youâre no longer tracking the same protein speciesâand that changes everything.
- The Hidden Burn: How Internal Misalignment Drains Your Biotechâs Runway
The date never changed. But the scope moved. If nothing changes after it, it was just a lab update. shared, milestone-driven roadmap tied to strategic decisions, not just scientific deliverables, momentum changes
- The Hidden Operating Cadence Thatâs Actually Driving Your Biotech
And until you see it, you canât change it. What must change? What deserves escalation? â A stable cadence doesnât eliminate surprise.
- How System-Level GPCR Thinking Prevents Discovery Failures
Johannes Broichhagen Reliable imaging tools change how researchers see receptor behavior. specificity, relevance, and assay confidence Read the full HCS feature †Why System-Level GPCR Thinking Changes
- Inverse Agonists, Lymphatic Fixes & ÎČ-arrestin Tricks
This week brings sharp new insights into how minor changes in ligand structure can flip GPCR function
- Transmembrane domains of GPCR dimers â a novel hot spot for drug discovery
al. highlight the importance of GPCR dimers in drug discovery referring to important conformational changes But what are the conformation changes that drive GPCR dimerization? The interaction between two receptors in a dimer involves a conformational change in the transmembrane Interestingly, the amplitude of the conformational changes due to ligand binding is limited at these
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
characterization of biased receptors may give insights into the relationship between the conformational change protein coupling bias of mutant AVPR2s may broaden our understanding of the relationship between the changed
- How Early Strategic Decision Making Creates Alignment and Better Results
They only feel the consequences months later, when it is hard to change momentum. đ This article is Why Results Appear Too Late to Change the Outcome đ Most teams focus on results because results feel underlying strategy is sound. đ When early strategic decision-making creates alignment, something changes
- SLAS2022 International Conference and Exhibition
We are closely monitoring any regulation changes from both Boston and Massachusetts with regard to in-person If there are any changes made that will impact our ability to hold the event in-person, we will notify
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
Furthermore, image-based data provide an additional check against off-target cytotoxicity or morphological changes Notably, no compound displayed toxicity or morphological changes at this concentration, supporting the evaluate affinity jumps between analogues, image data can help resolve questions such as: Is the signal change
- Dynamic recognition of naloxone, morphine and endomorphin1 in the same pocket of ”-opioid receptors
severe pain by activating the Ό-opioid receptor (MOR), whereas naloxone, with only slight structural changes The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
Additionally, pull-down experiments demonstrated that YM promotes similar conformational changes in both Together, these results indicate that changes in membrane binding impact the ability of YM to inhibit
- When Pain Becomes a Catalyst: How Personal Experience Redefined One Scientistâs Mission
But everything changed when his recurring pain â and the rigid protocols around opioid prescription â






















